Curating from trusted global sources…
75 briefings · “ark”
Roughly 206 million shares are sold short. The higher the bet against SpaceX gets, the higher the pressure on capital markets.
Chairman Jimmy Pitaro says ESPN is trimming roles as it folds NFL assets into the company post-acquisition.
A one-day emergency order collapses into a public reset, exposing how DHS enforcement rides politics and loyalty.
The marketing pivot from “evergreen” stunts to live moments helped drive a monoculture-shaped spike, and AI may be amplifying it.
As Silicon Valley battles algorithmic competition, regulation and capital markets are starting to force real choices.
A 14-minute AI-made film by the District 9 director sparked backlash over AI “slop” and technical uncanny issues.
A wide-ranging “strategic alliance” stitches a food-and-beverage powerhouse into Disney’s entertainment and experiences pipeline.
The lawsuit alleges Lilly's Zepbound and Mounjaro marketing leans on stale evidence to exaggerate efficacy versus rivals.
A fresh filing shows Nvidia owning about 22.26 million shares in Nebius, and markets reacted fast.
A court filing asks to block Lilly’s GLP-1 advertising and force corrections, raising the heat on drug marketing scrutiny.
A bid to amend the constitution collides with mounting opposition tactics, and Tshisekedi now swings toward talks.
The newborn-brain-injury biotech is betting on Hong Kong capital markets before a later US secondary listing.
